TASIS The American School in Switzerland welcomed Riccardo Braglia, Executive Chairman of Helsinn Group and Chairman of 3B Future Health Ventures, on November 10 for the second installment of the 2026–2027 TASIS Speaker Series. The visit provided students and faculty with direct exposure to a leader whose four-decade career in healthcare has driven global advancements in cancer supportive care and early-stage biotech innovation. As Executive Chairman of Helsinn Group, a Swiss pharmaceutical company with a focus on supportive care in oncology, Mr. Braglia has overseen the development and commercialization of therapies that improve the quality of life for patients undergoing cancer treatment worldwide. His role at 3B Future Health Ventures further reflects his commitment to nurturing early-stage biotech innovation, supporting ventures that aim to translate scientific discovery into practical clinical solutions. The TASIS Speaker Series, a flagship initiative of the school's high school academic program, brings distinguished individuals from diverse fields to campus to engage with students beyond the traditional classroom. By hosting figures such as Mr. Braglia, the series underscores the school's dedication to fostering intellectual curiosity, global awareness, and real-world connections. During his visit, Mr. Braglia shared insights from his professional journey, offering students a nuanced perspective on leadership in the pharmaceutical industry, the complexities of global health challenges, and the importance of innovation in addressing unmet medical needs. His presence at TASIS exemplified the school's ongoing effort to connect its community with influential thinkers and practitioners who can inspire the next generation of leaders.
Beyond his executive responsibilities, Riccardo Braglia brings a deeply personal dimension to his work in healthcare. As a cancer survivor, he is the author of The Journey Through the Desert, a book that reflects on his experiences and offers perspective on resilience and hope. His commitment to the broader fight against cancer is further evidenced by his active board memberships with Conquer Cancer (The ASCO Foundation) and the Helmut Horten Foundation, organizations that support research, patient care, and philanthropic initiatives in oncology and beyond. Mr. Braglia's dedication to global philanthropy extends to his role as co-founder of the New Flower (Nuovo Fiore) in Africa Foundation, which has constructed 38 schools supporting more than 50,000 students across sub-Saharan Africa. This foundation was once connected with the Opsahl Global Service Program at TASIS, reflecting a shared ethos of service and international understanding. In addition to his work in global health and philanthropy, Mr. Braglia intends to fly into space as an astronaut next year, a testament to his adventurous spirit and willingness to push boundaries. His visit to the school offered students a multifaceted view of leadership—one that encompasses scientific innovation, personal resilience, philanthropic impact, and the pursuit of extraordinary goals. By engaging with a speaker of such breadth, students at TASIS gained valuable exposure to the ways in which professional excellence can intersect with service to humanity and the exploration of new frontiers.